29 related articles for article (PubMed ID: 7529212)
21. Somatostatin analogues and small-cell lung carcinoma.
Taylor JE
Recent Results Cancer Res; 1993; 129():71-82. PubMed ID: 8102490
[No Abstract] [Full Text] [Related]
22. New short-chain analogs of a substance-P antagonist inhibit proliferation of human small-cell lung-cancer cells in vitro and in vivo.
Orosz A; Schrett J; Nagy J; Bartha L; Schön I; Nyéki O
Int J Cancer; 1995 Jan; 60(1):82-7. PubMed ID: 7529212
[TBL] [Abstract][Full Text] [Related]
23. Growth factor and peptide receptors in small cell lung cancer.
Moody TW; Cuttitta F
Life Sci; 1993; 52(14):1161-73. PubMed ID: 8383784
[TBL] [Abstract][Full Text] [Related]
24. Bombesin antagonists: experimental and clinical results.
Schütte J; Seeber S
Recent Results Cancer Res; 1993; 129():115-29. PubMed ID: 7688906
[No Abstract] [Full Text] [Related]
25. Preclinical studies on the broad-spectrum neuropeptide growth factor antagonist G.
Jones DA; Cummings J; Langdon SP; Smyth JF
Gen Pharmacol; 1997 Feb; 28(2):183-9. PubMed ID: 9013192
[TBL] [Abstract][Full Text] [Related]
26. Neuropeptides as autocrine growth factors in cancer cells.
Moody TW; Chan D; Fahrenkrug J; Jensen RT
Curr Pharm Des; 2003; 9(6):495-509. PubMed ID: 12570813
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin and the lung.
O'Byrne KJ; Carney DN
Lung Cancer; 1993 Dec; 10(3-4):151-72. PubMed ID: 7915618
[TBL] [Abstract][Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
